Human Vaccines & Immunotherapeuticsawards Top Reviewer of the YearEllis, RonaldRiedmann, Eva MAuthor information1Senior Vice President R&D and Chief Technology Officer; NasVax, Ltd.; Ness Ziona, Israel;2Acquisitions Editor; Landes Bioscience; Vienna, AustriaFebruary 2014*Correspondence to: Ronald Ellis; Email: [email protected]Submitted: 1/12/2014; Accepted: 1/12/2014 http://dx.doi.org/10.4161/hv.28446Human Vaccines & Immunotherapeutics 10(2):p 247-251, February 2014.Copyright © 2014 Landes Bioscience